Incidence of Silent Atrial Fibrillation in Patients With Clinically Silent Brain Ischemic Lesions Arterial Fibrillation (AF) is well-recognized as a cause for cryptogenic Acute Ischemic Stroke (AIS) and is associated with Silent Brain Infarction...

Clinical Studies - Dec 4, 2020 - Dec 4, 2024

Ongoing

Project leader: Ammann Peter, Kägi Georg
Members: Brenner Roman, Vetsch Susanne, Schneider Irene

Study Hypothesis: In patients with evidence of device-detected sub-clinical atrial fibrillation (SCAF) and additional risk factors for stroke, treatment with apixaban compared with aspirin will reduce the risk of the composite of stroke and systemic...

Clinical Studies - Apr 1, 2016 - Jan 1, 2026

Ongoing

Project leader: Ammann Peter
Members: Gemperle Michaela, Brenner Roman, Fink Karin, Vetsch Susanne

To increase our knowledge on structural brain damage and its changes over time in patients with AF 2. To gain additional insights on the incidence and underlying mechanisms of cognitive decline in patients with AF 3. To improve long term risk pre...

Clinical Studies - Jun 12, 2014 - Jan 1, 2032

Ongoing

Project leader: Ammann Peter
Members: Altmann David, Gemperle Michaela, Kopp Sebastian, Fink Karin, Brenner Roman, Vetsch Susanne

Die Studie ist eine prospektive invasive, longitudinale Pilot Studie an hyperthyreoten Patienten mit Frage nach pulmonaler Hypertonie; 2.1 Häufigkeit der pulmonalen Hypertonie bei Patienten mit Hyperthyreose 2.1.1. Definition der pulmonalen Hyper...

Clinical Studies - Jun 1, 2012 - Dec 31, 2022

Completed

Project leader: Ammann Peter, Brändle Michael
Members: Locher Rebecca, Gemperle Michaela, Drescher Tilman, Vetsch Susanne, Schneider Irene, Brenner Roman